The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management.


Journal

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
ISSN: 1439-4286
Titre abrégé: Horm Metab Res
Pays: Germany
ID NLM: 0177722

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 13 10 2020
medline: 1 10 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

This review aims to explore, present, and discuss disorders of glucose metabolism implicated in pituitary gland diseases, the appropriate interventions, as well as the therapeutic challenges that may arise. Pituitary pathologies may dysregulate glucose homeostasis, as both the excess and deficiency of various pituitary hormones can affect glucose metabolism. Increased circulating levels of growth hormone, glucocorticoids or prolactin have been shown to mainly provoke hyperglycemic states, while hypopituitarism can be associated with both hyperglycemia and hypoglycemia. Addressing the primary cause of these disorders with the use of surgery, medical treatment or radiotherapy forms the cornerstone of current management strategies. Physicians should bear in mind that some such medications have an unfavorable effect on glucose metabolism too. When unsuccessful, or until the appropriate treatment of the underlying pituitary problem, the addition of established antidiabetic therapies might prove useful. Further studies aiming to discover more accurate and effective drug preparations in combination with optimal lifestyle management models will contribute to achieving a more successful glycemic control in these patients.

Identifiants

pubmed: 33045752
doi: 10.1055/a-1258-8625
doi:

Substances chimiques

Glucose IY9XDZ35W2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-23

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Guy I Sydney (GI)

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Konstantinos Michalakis (K)

Imperial College of Medicine, London, UK.

Ilias P Nikas (IP)

School of Medicine, European University Cyprus, Nicosia, Cyprus.

Eleftherios Spartalis (E)

2nd Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Athens, Greece.

Stavroula A Paschou (SA)

School of Medicine, European University Cyprus, Nicosia, Cyprus.
School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH